ZVRA FY 2022 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-64.5% YoY

Gross Profit

$10M97.8% margin

Operating Income

-$43M-418.9% margin

Net Income

-$27M-263.5% margin

EPS (Diluted)

$-0.78

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$115M

Total Liabilities

$40M

Stockholders' Equity

$75M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$29M	-64.5%
Gross Profit	$10M	$27M	-62.6%
Operating Income	-$43M	$8M	-650.7%
Net Income	-$27M	-$9M	-212.9%